CPG Diagnostics Inc is a Pasadena-based company dedicated to improving the detection and management of ovarian cancer. Their innovative solution, OvaPrint, is a circulating tumor DNA blood test that can diagnose ovarian cancer pre-operatively in women with pelvic masses, including early-stage cases, addressing the limitations of existing tests.
By enabling the detection of ovarian cancer prior to surgery, CPG Diagnostics Inc aims to ensure that women with pelvic masses receive appropriate referrals and timely medical intervention. With their mission to rule in or out ovarian cancer, the company is committed to saving lives through early detection and improved patient care.
Generated from the website